Patients Achieving a HbA1c Less Than 5.7% with Greater Than or Equal to 5% Weight Loss and Without Hypoglycaemia: A Post Hoc Analysis of SURPASS 1 to 5
Diabetologie und Stoffwechsel(2023)
摘要
Question What is the proportion of participants treated with tirzepatide achieving a HbA1c<5.7% [< 30 mmol/mol] with > 5% weight loss and no hypoglycemia relative to placebo and active comparators?
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要